These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
282 related items for PubMed ID: 8053695
1. Risk factors for melanoma incidence in prospective follow-up. The importance of atypical (dysplastic) nevi. Schneider JS, Moore DH, Sagebiel RW. Arch Dermatol; 1994 Aug; 130(8):1002-7. PubMed ID: 8053695 [Abstract] [Full Text] [Related]
2. The impact of total body photography on biopsy rate in patients from a pigmented lesion clinic. Risser J, Pressley Z, Veledar E, Washington C, Chen SC. J Am Acad Dermatol; 2007 Sep; 57(3):428-34. PubMed ID: 17624623 [Abstract] [Full Text] [Related]
3. Risk of cutaneous malignant melanoma in patients with 'classic' atypical-mole syndrome. A case-control study. Marghoob AA, Kopf AW, Rigel DS, Bart RS, Friedman RJ, Yadav S, Abadir M, Sanfilippo L, Silverman MK, Vossaert KA. Arch Dermatol; 1994 Aug; 130(8):993-8. PubMed ID: 8053716 [Abstract] [Full Text] [Related]
4. Melanoma risk in individuals with clinically atypical nevi. Kang S, Barnhill RL, Mihm MC, Fitzpatrick TB, Sober AJ. Arch Dermatol; 1994 Aug; 130(8):999-1001. PubMed ID: 8053717 [Abstract] [Full Text] [Related]
5. Dysplastic nevi and other risk markers for melanoma. Seykora J, Elder D. Semin Oncol; 1996 Dec; 23(6):682-7. PubMed ID: 8970587 [Abstract] [Full Text] [Related]
7. [Connection between uveal melanoma and dysplastic naevus syndrome]. Hammer H, Tóth-Molnár E, Oláh J, Dobozy A. Magy Onkol; 2005 Dec; 49(1):15-8. PubMed ID: 15902328 [Abstract] [Full Text] [Related]
8. Ocular melanoma: epidemiology, clinical presentation and relationship with dysplastic nevi. Richtig E, Langmann G, Müllner K, Smolle J. Ophthalmologica; 2004 Dec; 218(2):111-4. PubMed ID: 15004500 [Abstract] [Full Text] [Related]
9. [Family studies on the incidence of multiple pigmented naevi, familial skin melanoma and other malignant tumors]. Szekeres L, Korom I. Orv Hetil; 1991 Sep 29; 132(39):2153-6. PubMed ID: 1923488 [Abstract] [Full Text] [Related]
10. Dysplastic nevi as risk markers of sporadic (nonfamilial) melanoma. A case-control study. Halpern AC, Guerry D, Elder DE, Clark WH, Synnestvedt M, Norman S, Ayerle R. Arch Dermatol; 1991 Jul 29; 127(7):995-9. PubMed ID: 2064418 [Abstract] [Full Text] [Related]
15. Effect of neonatal phototherapy on melanocytic nevus count in children. Matichard E, Le Hénanff A, Sanders A, Leguyadec J, Crickx B, Descamps V. Arch Dermatol; 2006 Dec 29; 142(12):1599-604. PubMed ID: 17178986 [Abstract] [Full Text] [Related]
16. Dysplastic nevus--risk factor or disguise for melanoma. Dediol I, Bulat V, Zivković MV, Marković BM, Situm M. Coll Antropol; 2011 Sep 29; 35 Suppl 2():311-3. PubMed ID: 22220461 [Abstract] [Full Text] [Related]
19. Selection of patients for long-term surveillance with digital dermoscopy by assessment of melanoma risk factors. Haenssle HA, Korpas B, Hansen-Hagge C, Buhl T, Kaune KM, Johnsen S, Rosenberger A, Schön MP, Emmert S. Arch Dermatol; 2010 Mar 29; 146(3):257-64. PubMed ID: 20231495 [Abstract] [Full Text] [Related]
20. A natural history of melanomas and dysplastic nevi: an atlas of lesions in melanoma-prone families. Tucker MA, Fraser MC, Goldstein AM, Struewing JP, King MA, Crawford JT, Chiazze EA, Zametkin DP, Fontaine LS, Clark WH. Cancer; 2002 Jun 15; 94(12):3192-209. PubMed ID: 12115352 [Abstract] [Full Text] [Related] Page: [Next] [New Search]